
By Staff Reporter
A major new scientific review led by UCLA Health has cast doubt on the effectiveness of medical cannabis in treating widely reported conditions such as chronic pain, anxiety and insomnia, challenging popular perceptions around its medical benefits.
The review, published on Friday in the Journal of the American Medical Association (JAMA), analysed more than 2,500 scientific studies published between 2010 and 2025. From these, researchers closely examined over 120 high-quality sources, including clinical trials, meta-analyses and established medical guidelines.
According to the findings, there is limited or inconsistent scientific evidence to support the use of medical cannabis for most conditions for which it is commonly prescribed or self-administered. While cannabis and cannabinoid products—such as CBD—have gained widespread acceptance as alternative treatments, the review suggests that scientific backing has not kept pace with public enthusiasm.
Lead author Dr Michael Hsu of UCLA Health said the findings highlight a significant gap between public expectations and current medical evidence.
“Scientific evidence does not strongly support the use of medical cannabis for most medical conditions people commonly use it for,” Dr Hsu said, adding that the results underscore the need for more rigorous, condition-specific research.
The study comes at a time when medical cannabis use is rapidly expanding globally, driven by changing laws, aggressive marketing and growing public perception that cannabis-based treatments are safe and effective alternatives to conventional medicine.
Researchers caution that while some limited benefits may exist for specific conditions, the overall evidence remains insufficient to justify broad medical use. They also stress the importance of clinicians relying on proven, evidence-based treatments rather than assumptions shaped by popularity or anecdotal claims.
The authors conclude that patients and healthcare providers should approach medical cannabis with caution and advocate for more high-quality clinical research to clearly define where—if at all—it offers meaningful medical benefit.
You may also like
CAMA Warns of K20,000 Fuel Black Market as NOCMA Seeks 440,000 Tonnes of Fuel
By MFN News Desk TeamMalawi Freedom Network | 9 October 2026 Malawi’s persistent fuel shortage has…
Rhodrick Kalumpha Donates K6 Million to Chiwanja cha Ayao Cultural Ceremony
By MFN News Desk TeamOctober 10, 2026 | Malawi Malawian business strategist Rhodrick Junaid Kalumpha has…
Health Minister Baloyi Threatens Permanent Ban on Drug Suppliers Who Misdeclare Stocks
By MFN News Desk TeamPublished: 9 October 2026 | 05:06 AM CAT Malawi’s Minister of Health…
Are Muslims Being Sidelined in President Mutharika’s Cabinet?
By Kakwe Mkaulire Since assuming office following the landmark 2025 elections, President Arthur Peter Mutharika has…
Critics Accuse MCP Leadership of Neglecting Environment and Public Welfare
By Mawa kumaliwopa Political debate continues in Malawi as some citizens and opposition supporters have voiced…
China scraps tariffs for all but one African nation
By Suleman Chitera Sino-African trade is marked by a growing imbalance in China's favour China will…
You may also like
Ansah reveals she sent over 70 Memos to Mutharika, rubbishes rift claims
"Diligently serving the country has always been my motto." By Malawi Freedom Network | June 19,…
Amaryllis Hotel public inquiry finishes questions still there
By Vincent Gunde The parliamentary Public Inquiry on the sale of Amaryllis Hotel has finished and…
Over 900 Malawians Stranded at Mwanza Border After Returning from South Africa
By Contributor Mwanza, Malawi – More than 900 Malawian nationals who have returned from South Africa…
Malawi Government Intervenes in Tobacco Market as Minister Roza Mbilizi Orders Fair Prices for Farmers
By Suleman Chitera The Malawi Government has stepped in to address growing concerns from tobacco farmers…
Questions Mount Over Alleged Use of Nkhotakota District Council Resources in Court Case Involving Chairperson Fitton Khofi
By Suleman Chitera Questions are intensifying over the alleged handling and possible use of public resources…
UGI contributes K15m to MUBAS Research and Innovation Conference
By Takondwa Nyirenda, Contributor United General Insurance Company Limited (UGI) has donated K15 million to Malawi…














